An institutional Ethereum bull has sold almost all of its ETH stash in a capitulation move that has caught the attention of the market.An institutional Ethereum bull has sold almost all of its ETH stash in a capitulation move that has caught the attention of the market.
Institutional ETH Holder Capitulates With 772,865 ETH Deposit to Binance
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
An institutional Ethereum bull has sold almost all of its ETH stash in a capitulation move that has caught the attention of the market.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
Claude Code has been found to have two caching bugs that could silently increase API costs by 10-20 times.
PANews reported on March 31 that, according to 1M AI News, a developer reverse-engineered a 228MB binary file of the standalone Claude Code installer using Ghidra
Share
PANews2026/03/31 11:37
US President Trump willing to end Iran war without reopening Strait of Hormuz – WSJ
The post US President Trump willing to end Iran war without reopening Strait of Hormuz – WSJ appeared on BitcoinEthereumNews.com. Citing administration officials
Share
BitcoinEthereumNews2026/03/31 11:02
NextGen Scientific Corrects Details of $10 Million Capital Raise for Oncology and Dermatology Investments
NextGen Scientific issues corrected $10M private placement to fund oncology drug development & nutraceutical business. Details on GZ17-6.02 & GZ21T clinical trials
Share
Citybuzz2026/03/31 11:00
